Cumberland Pharmaceuticals (CPIX) Interest Coverage Ratio (2010 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Interest Coverage Ratio came in at 4365.28 in Q2 2026, up 34.09% year-over-year from 3255.46 in Q2 2025, and down 11874.31% quarter-over-quarter from 36.46 in Q1 2026.
Analysis
Cumberland Pharmaceuticals (CPIX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Interest Coverage Ratio across 17 years of filings, most recently posting 4365.28 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio rose 34.09% year-over-year to 4365.28; the TTM figure through Jun 2026 stood at 31.13 (down 204.65% YoY), while the FY2025 annual figure was 5.63, up 47.01% from the prior year.
- Interest Coverage Ratio came in at 4365.28 for Q2 2026 at Cumberland Pharmaceuticals, down from 36.46 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 7.89 in Q1 2025 to a low of 6623.18 in Q2 2025.
- Average Interest Coverage Ratio over 5 years is 621.67, with a median of 12.51 recorded in 2022.
- The largest YoY upside for Interest Coverage Ratio was 150.01% in 2025 against a maximum downside of 81406.67% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 12.69 in 2022, then plunged by 172.29% to 34.56 in 2023, then jumped by 76.13% to 8.25 in 2024, then sank by 47.15% to 12.14 in 2025, then slumped by 35855.55% to 4365.28 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 4365.28 in Q2 2026, 36.46 in Q1 2026, and 12.14 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -21.24 |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 114.07 |
| 10 | Cumberland Pharmaceuticals | 95.51 Mn | 91.65 Mn | - | -4,365.28 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,365.28 |
| Mar 31, 2026 | -36.46 |
| Dec 31, 2025 | -12.14 |
| Sep 30, 2025 | -17.92 |
| Jun 30, 2025 | -6,623.18 |
| Mar 31, 2025 | 7.89 |
| Dec 31, 2024 | -8.25 |
| Sep 30, 2024 | -12.33 |
| Jun 30, 2024 | -8.13 |
| Mar 31, 2024 | -15.77 |
| Dec 31, 2023 | -34.56 |
| Sep 30, 2023 | -16.96 |
| Jun 30, 2023 | 0.12 |
| Mar 31, 2023 | -8.22 |
| Dec 31, 2022 | -12.69 |
| Sep 30, 2022 | -1.93 |
| Jun 30, 2022 | -13.42 |
| Mar 31, 2022 | -10.80 |
| Dec 31, 2021 | -156.99 |
| Sep 30, 2021 | -78.09 |